12 February 2020 - Deborah Wilkes
Archived
Sanofi's Consumer Healthcare business reported worldwide sales down by 5.2% at constant exchange rates in the fourth quarter of 2019. The company said the fall was due to the voluntary recall of Zantac (ranitidine), non-core brand divestments, and product suspensions due to changing regulatory requirements, particularly in Europe.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.